Background. Brain-derived neurotrophic factor (BDNF) blocks activation of caspase-3, reduces translocation of apoptosis-inducing factor (AIF), attenuates excitotoxicity of glutamate, and increases antioxidant enzyme activities. The mechanisms of neuroprotection suggest that BDNF may be beneficial in bacterial meningitis.
incidence of neurological sequelae, with up to half of the survivors presenting some form of neurological sequelae [6, 7] .
In humans and in experimental animal models, bacterial meningitis causes neuronal injury to the cortical and subcortical regions [8] [9] [10] [11] . Three distinct forms of neuronal cell death have been documented. In the cortex, neurons undergo ischemic damage, leading to cellular necrosis in the ischemic core and to caspase-3-dependent cell death in the penumbra [12] [13] [14] [15] . Two different forms of cell death have been identified in the dentate gyrus of the hippocampus, a region important for learning and memory: classic caspase-3-dependent cell death (i.e., apoptosis) primarily affects the subgranular zone containing recently divided immature neurons, whereas caspase-3-independent cell death (i.e., pyknosis) occurs throughout the dentate granular cell layer, affecting both mature and immature neurons [16] .
Neurotrophins, a family of the neurotrophic factors, control neuronal cell death in development and play an important role in neuronal differentiation and sur-vival [12] [13] [14] [15] . Brain-derived neurotrophic factor (BDNF) is of particular interest, since its receptor (trkB) is found in a broad range of neuronal cell types and is highly expressed in the hippocampus. Because of its neuroprotective effects, BDNF holds promise as a treatment for diseases of the central nervous system (CNS) . In several studies of ischemic-hypoxic injury, BDNF exhibited marked antiapoptotic effects by blocking activation of caspase-3 [17, 18] . Furthermore, BDNF attenuated the nuclear translocation of apoptosis-inducing factor (AIF) [19] , which can be a mediator of caspase-3-independent cell death.
Given the neuroprotective effect of administration of BDNF in various models of neuronal injury, we decided to evaluate the neuroprotective effect of BDNF in experimental meningitis, using a well-characterized infant rat model that mimics important features of the human disease and exhibits all 3 forms of neuronal injury associated with bacterial meningitis [15, 16, [20] [21] [22] [23] . We took advantage of the fact that the extent of the various forms of injury depends on the infecting pathogen. Bacterial meningitis due to Streptococcus pneumoniae primarily induces apoptosis and, to a much lesser extent, pyknosis, whereas the reverse is true for meningitis due to group B streptococci (GBS) [16] . Thus, depending on the form of injury investigated, we used one or the other infecting pathogen to examine the effect of adjuvant administration of BDNF. The effect of BDNF on apoptotic cell death in the dentate gyrus of the hippocampus was analyzed by use of S. pneumoniae as the infecting pathogen, whereas its effect on caspase-3-independent cell death and cortical necrosis was analyzed by use of GBS as the infecting pathogens.
MATERIALS AND METHODS

Infecting pathogens.
To maximize the extent of the various forms of neuronal injury, we used a type III GBS isolate to examine cortical necrosis and caspase-3-independent cell death in the dentate gyrus and a serotype 3 S. pneumoniae isolate to examine hippocampal apoptotic cell death. Both organisms were initially isolated from patients with bacterial meningitis and had been passaged repeatedly through animals. The organisms were grown on blood-agar plates, cultured overnight in 10 mL of brain-heart infusion medium, diluted in fresh medium, and grown for 6 h to logarithmic phase. The culture broth was centrifuged for 10 min at 5000 g, pelleted, resuspended in sterile saline to the desired density, and used for intracisternal injection. The accuracy of the inoculum size was confirmed by quantitative cultures.
Model of meningitis. The animal studies were approved by the Animal Care and Experimentation Committee of the Canton of Bern, Switzerland, and followed National Institutes of Health guidelines for the performance of animal experiments. Nursing Sprague-Dawley rat pups ( ) were infected on n p 60 postnatal day 11 by intracisternal injection of 10 mL of saline containing either S. pneumoniae (log 10 cfu/mL; 7.5 ‫ע‬ 0.4 n p ) or GBS (log 10 cfu/mL; ). Infected rats were 20 7.6 ‫ע‬ 0.9 n p 40 randomized for repeated intracisternal injections of either 3 mg/kg BDNF per dose (provided by Regeneron Pharmaceuticals) or equal volumes (10 mL) of saline at 0, 6, 12, 15, 18, and 21 h after infection. Eighteen hours after intracisternal injection, rats were weighed and assessed clinically, as described elsewhere [24] . To document meningitis, 10 mL of cerebrospinal fluid (CSF) was obtained by puncture of the cisterna magna and was cultured quantitatively by serial dilutions. Infected rats then received 1 subcutaneous injection of 100 mg/kg ceftriaxone (Roche Pharma).
Histopathological examination. For histopathological examination, rats were killed h ( ) after in-22 ‫ע‬ 0.5 mean ‫ע‬ SD fection. Rats that died spontaneously or that had to be killed for ethical reasons before 21 h after infection were not included (
). After perfusion with 4% paraformaldehyde in PBS, 12 n p 19 coronal sections from the frontal, middle, and dorsal brain region were mounted on polylysine-coated slides and Nissl stained with cresyl blue. Forty-one rats were evaluated for cortical and hippocampal injury: 9 were infected with S. pneumoniae and treated with saline, 7 were infected with S. pneumoniae and treated with BDNF, 14 were infected with GBS and treated with saline, and 11 were infected with GBS and treated with BDNF.
Cortical necrosis, defined as areas of reduced neuronal density with neurons displaying morphological features of necrosis, including cell swelling and loss of cytoarchitecture ( figure 1A) , was assessed as a percentage of total cortex, and a mean percentage per rat was calculated from all evaluated sections [25] . In the dentate gyrus of the hippocampus, the extent of neuronal injury was scored by use of bright-field microscopy. Pyknosis, which is characterized morphologically by uniformly shrunken nuclei, forming clusters of damaged cells predominantly in the lower blade of the dentate granule cell layer (figure 1B), was assessed in the 4 blades of the structure and, if present, was scored as 1 point for each blade (maximum, 4 points/section) [16] . The median score for each rat was calculated from all sections evaluated. For apoptosis, cells with morphological features of apoptosis (condensed, fragmented nuclei and apoptotic bodies) (figure 1C) were counted in 3 visual fields (magnification, ϫ400) in each of the 4 blades of the dentate gyrus, and the following scoring system was applied for the count in each blade: 0-5 cells, 0; 6-20 cells, 1; and 120 cells, 2 [15] . The median score per rat was calculated from all sections evaluated. All histopathological examinations were performed by an investigator who was unaware of the clinical, microbiological, and treatment data for the respective rat.
Immunhistochemical analysis. For immunohistochemical analysis, rats were killed and perfused with PBS, and their brains ; cresyl violet staining). B, Pyknosis in the dentate gyrus of the hippocampus, containing clustered cells with dense and shrunken nuclei (see insert for magnification ϫ1200), spanning the entire blade of the dentate gyrus (arrowheads). The lower blade was consistently more severely affected than the upper blade (original magnification, ϫ400; cresyl violet staining). C, Apoptosis in the subgranular zone. Neurons with condensed and fragmented nuclei (see insert for magnification ϫ1200) are scattered along the subgranular zone (arrowheads) (original magnification, ϫ400; cresyl violet staining). were embedded in paraffin. Two-micrometer sections were cut, mounted, deparaffinized, and hydrated. The sections were rinsed with PBS, incubated overnight at 4ЊC with the primary antibody for AIF (provided by G. Kroemer, Institut Gustave Roussy, France), and diluted 1:200 in antibody buffer (1/1 [vol/ vol] 0.5% bovine serum albumin in PBS and 0.5 mol/L Tris buffer [pH 7.6] in 0.88% NaCl). Sections were then washed in PBS and incubated for 1 h at room temperature with the secondary antibody (Alexa Fluor 488; Molecular Probe), diluted 1:1000 in antibody buffer. Nuclei were counterstained with 4'-6-diamidino-2-phenylindole (DAPI).
Statistical methods. The clinical parameters were compared by use of the unpaired Student's t test. Neuronal injury was analyzed by use of the Mann-Whitney U test. was P ! .05 considered to be significant.
RESULTS
Characteristics of disease.
Eighteen hours after infection, all rats had documented meningitis, with lethargy and positive bacterial cultures in CSF. Compared with treatment with saline, treatment with BDNF had no effect on CSF bacterial titers, clinical score, or survival (table 1) . However, rats treated with BDNF lost significantly more weight than did rats treated with saline (table 1) . This increased weight loss was presumably due to the appetite suppression known to be associated with central application of BDNF [26] .
Effect of treatment with BDNF on cortical necrosis. The effect of treatment with BDNF on ischemic cortical necrosis was evaluated in rats infected with GBS. Among infected, salinetreated rats, 11 of 14 showed necrosis (median, 21.3%; range, 0.0%-55.3%). The appearance of cortical injury was characteristic of the patterns described previously in this model [21] [22] [23] , with focal, often wedge-shaped areas of neuronal loss (figure 1A) . Treatment with BDNF significantly ( ) reduced P ! .03 the incidence and extent of cortical injury ( figure 2A ). Only 3 of 11 infected, BDNF-treated rats had cortical injury (median 0.0%; range, 0.0%-33.7%).
Effect of treatment with BDNF on caspase-3-independent cell death in the hippocampus.
Caspase-3-independent cell death in the hippocampus has previously been reported to be associated primarily with GBS infection [16] . Accordingly, the effect of BDNF on this form of injury was assessed in the rats infected with GBS. Among infected, saline-treated rats, 10 (71%) of 14 showed evidence of this form of neuronal injury, with a median score of 0.88 (range, 0-3.25). Treatment with BDNF significantly reduced this form of hippocampal cell death, with only 2 (19%) of 11 infected, BDNF-treated rats showing neuronal damage, with a median score of 0 (range, 0-2) ( ) P ! .02 ( figure 2B) .
Nuclear translocation of AIF in caspase-3-independent cell
death. The nature of the caspase-3-independent cell death in this model of meningitis due to GBS has not been clarified [16] . Previous studies have suggested that, in bacterial meningitis, some forms of neuronal injury in the hippocampus may be associated with nuclear translocation of AIF [27] . Since BDNF can block nuclear translocation of AIF [19] and since it was effective in reducing caspase-3-independent cell death in the present study, we reasoned that this form of injury may be associated with nuclear translocation of AIF. Staining for AIF by use of fluorescent immunhistochemical analysis documented the presence of AIF in the cytoplasm of normally appearing cells in the dentate gyrus. In contrast, in cells that, by DAPI staining, showed evidence of injury (i.e., condensed, shrunken, and rounded nuclei), AIF was consistently localized to the nucleus ( figure 3) . Thus, the pyknotic form of hippocampal neuronal injury in bacterial meningitis is associated with nuclear translocation of AIF, and BDNF prevents this form of injury, presumably by inhibiting nuclear translocation of AIF. Effect of therapy with BDNF on hippocampal apoptosis. Caspase-3-dependent apoptosis was evaluated in the model of meningitis due to S. pneumoniae. As reported elsewhere [16] , infection with S. pneumoniae consistently led to cells showing apoptotic morphological features in the subgranular zone of the dentate gyrus. In rats infected with S. pneumoniae and treated with saline, the median score of apoptotic neurons was 1.10 (range, 0.08-1.56). Treatment with BDNF significantly reduced the extent of this form of injury (median score, 0.33; range, 0.0-1.0; ) ( figure 2C) . P ! .05
DISCUSSION
Since the discovery of the potent survival-promoting effects of neurotrophic factors, there has been the hope that they can be used successfully in treating diseases of the CNS. BDNF is of particular interest in this regard, since its receptor (trkB) is expressed in a broad range of neurons throughout the brain [28] , which is a prerequisite for a beneficial effect in diseases affecting multiple regions of the brain, as is the case in bacterial meningitis. Several studies have demonstrated the beneficial effect of BDNF in treating ischemia, trauma, and excitotoxicity [17, 18, 29, 30] . In the present study, we have demonstrated that adjuvant therapy with BDNF in experimental bacterial meningitis protects the brain from 3 distinct forms of injury: necrosis affecting the cortex and caspase-3-dependent and -independent cell death in the hippocampal dentate gyrus.
Bacterial meningitis causes wedge-shaped lesions in the cortex, defined by neuronal loss and morphological features of cellular necrosis (cell swelling and fading of cytoarchitecture) [25] . The results of several experimental studies have supported the importance of ischemia as a central mechanism in cortical necrosis. For example, inhibition of the endogenous vasoconstrictors endothelins with a nonselective receptor antagonist (bosentan) protected infant rats with pneumococcal meningitis from a reduction in cerebral blood flow and simultaneously reduced cortical injury [25] . Along the same line, inhibition of the production of the vasodilative nitric oxide with an inhibitor of inducible nitric oxide synthase (aminoguanidine) reduced cerebral blood flow and increased cortical necrotic damage [31] .
The mechanisms by which BDNF protects from ischemic injury in bacterial meningitis are not clear. Cellular calcium overload plays a role in a variety of CNS insults, particularly in conjunction with excitatory amino acids (EAAs) [32] . BDNF can enhance the binding capacity of intracellular calcium and thereby increase cell survival [33] . In bacterial meningitis, levels of EAAs are increased in interstitial brain fluid [34] , and an antagonist of neuronal EAA receptors (kynurenic acid) attenuates cortical injury [22] . Thus, by neutralizing the potentially detrimental effects of increased intracellular calcium, BDNF may preserve neurons from necrosis.
A further possible explanation for the beneficial effect of BDNF in experimental meningitis may be related to its ability to increase antioxidant enzyme activities and thus attenuate the harmful effects of reactive oxygen species [30] . Adjuvant antioxidants reduce cortical injury in models of bacterial meningitis, possibly through preservation of cerebral blood flow [21, 35] .
In the hippocampus, bacterial meningitis causes caspase-3dependent apoptosis of neurons, including recently divided immature neurons located in the subgranular zone of the dentate gyrus [15, 16] . In a neonatal hypoxia-ischemia model, BDNF has been shown to be protective against caspase-3-dependent cell death by blocking activation of caspase-3 through the trkB receptor [18] . Interestingly, this receptor, which mediates progenitor cell survival and neurogenesis, is expressed in the same region where caspase-3-dependent cell death affects progenitor cells in meningitis [16] . The inhibitory activity of BDNF on caspase-3-mediated proapoptotic pathways is likely responsible for its beneficial effect on caspase-3-dependent cell death in the present study.
Pyknosis (i.e., caspase-3-independent cell death) is distinct from apoptosis (i.e., caspase-3-dependent cell death) and is characterized by cell clusters with dense and shrunken nuclei that are TUNEL negative and fail to express activated caspase-3 [16] . In the present study, we found that BDNF also protected against this form of injury. The beneficial effect of BDNF on caspase-3-independent cell death has been documented in a model of retinal detachment in rats, in which cell death was shown to be induced by the translocation of AIF into the nucleus [19] . Furthermore, a recent study analyzing caspase-3independent cell death documented that nuclear translocation of AIF was triggered by glucose deprivation and ischemia, conditions that frequently affect the brain during meningitis [36] . We therefore explored whether nuclear translocation of AIF occurred in our model of meningitis due to GBS [16, 27] . Indeed, pyknotic cells in the dentate gyrus consistently showed immunocytochemical evidence of AIF in the nucleus. This result suggests that the protective effect of BDNF against pyknosis seen in the present model of bacterial meningitis is related to its capacity to interfere with nuclear translocation of AIF.
In conclusion, BDNF is neuroprotective against 3 distinct forms of neuronal cell injury in bacterial meningitis. These findings are of particular interest in light of recent findings that production of BDNF increases during meningitis at both the transcriptional and translational level, whereas treatment with antibiotics reduces production of BDNF [37] . It thus appears that BDNF is part of an endogenous protective pathway during meningitis and that external administration in parallel to antibiotic treatment of bacterial meningitis has the potential to reduce neuronal cell injury and, possibly, long-term neurological sequelae.
